Moreover, the application of GDC-0879 significantly reversed the pro-tumorigenic TAMs to pro-inflammatory phenotype, which indicated its potential to unbound the suppression of TAMs on immunosurveillance in TME and enhanced cytotoxic CD8 + T cell infiltration, which improved cancer response to anti-PD1. This evidence concerns the gene CD8A and cancer.